OncLive | Bringing the Global Oncology Community Together

Richard T. Silver, MD, discusses the history of interferon and shares insight on why the drug still holds its place in the treatment of patients with MPNs Read More >>

Eng Highlights Important Treatment Considerations in mCRC

TCT 2019: Pretransplant MRD Prognostic for Outcomes in Adults With ALL

Expert Discusses Evolution, Impact of Interferon in MPNs

Genomics Guide Treatment Escalation, De-Escalation in HR+ Breast Cancer

TCT 2019: Expert Highlights Encouraging PFS Data With Maintenance Ixazomib in Multiple Myeloma

View More Stories >>

View Conference Coverage

2019 Genitourinary Cancers Symposium

2019 Transplantation and Cellular Therapy Meetings

2019 Winter Lung Cancer Conference

2019 SGO Winter Meeting

2019 Gastrointestinal Cancers Symposium

Dr. Cohen Discusses Research Questions in Head and Neck Cancer

Dr. Tawbi on Unmet Needs in Melanoma

Dr. Shao on Prognosis of Patients With HER2+ Breast Cancer

Dr. Jhaveri Discusses the Potential of Immunotherapy in TNBC

Dr. Lee on the Benefit of Cytoreductive Surgery in Metastatic Colorectal Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Cause for Optimism in Follicular Lymphoma Treatment

Emerging Therapies and Combinations

$Proteasome Inhibitors in Relapsed-Refractory Myeloma$

Proteasome Inhibitors in Relapsed-Refractory Myeloma

Systemic Therapy Vs Radiotherapy for Small Brain Mets

OncLive houses thousands of videos that provide updates and information.
See more Videos

High-Risk Smoldering Multiple Myeloma: Systemic Therapy

Smoldering Multiple Myeloma Treatment Considerations

MCL: Novel BTK Inhibitor Combination Strategies

$Identifying Unmet Needs in Relapsed/Refractory MCL$

Multidisciplinary Management: Selecting a Therapy

The Role of Neoadjuvant Therapy in Pancreatic Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>